Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

Abstract

Erratum to: Diabetologia DOI 10.1007/s00125-010-1922-6 Unfortunately, the values for urinary ACR in the ‘Month 6 characteristics’ section of Table 1 were incorrect. They should have read 124 (46–249) for those in the group with serum potassium <5.0 mmol/l and 139 (51–291) for those in the group with serum potassium ≥5.0 mmol/l.